Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Curr Drug Targets ; 22(16): 1825-1831, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33593258

RESUMEN

The socio-economic burden of renal disease is enormous due to the unavailability of effective treatment to cure it. High risk patients have only two costly options in chronic renal disease, dialysis and renal replacement therapy (RRT). RRT has limitations of the organ donor, and ethical concerns are also associated with it. The Wnt/beta-catenin pathway is highly conserved and active during embryogenesis in early life but suppressed in adults. Animal studies suggested that knockdown of Wnt protein led to abnormal kidney development at birth. In the adult kidney, Wnt/beta-- catenin pathway activation led to tissue repair after acute injury, but sustained activation is harmful and involved in renal fibrosis. Recently, Wnt/beta-catenin signaling cascade has emerged as a potential pathway involved in adult renal diseases and is considered an attractive therapeutic target for developing effective therapeutic intervention. Precise information about the involvement of specific types of Wnt/beta-catenin pathway components in adult renal disease using cutting-edge molecular techniques will help develop novel therapies for renal diseases. Future studies will determine Wnt/beta-catenin signaling proteins' effectiveness and safety as a treatment option for renal disorders.


Asunto(s)
Insuficiencia Renal Crónica , Vía de Señalización Wnt , Animales , Humanos , Insuficiencia Renal Crónica/tratamiento farmacológico , Insuficiencia Renal Crónica/metabolismo , Proteínas Wnt/metabolismo , beta Catenina/metabolismo
2.
OMICS ; 23(11): 517-538, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-31613700

RESUMEN

This expert review offers a critical synthesis of the latest insights and approaches at targeting the Wnt/ß-catenin pathway in various cancers such as colorectal cancer, melanoma, leukemia, and breast and lung cancers. Notably, from organogenesis to cancer, the Wnt/ß-catenin signaling displays varied and highly versatile biological functions in animals, with virtually all tissues requiring the Wnt/ß-catenin signaling in one way or the other. Aberrant expression of the members of the Wnt/ß-catenin has been implicated in many pathological conditions, particularly in human cancers. Mutations in the Wnt/ß-catenin pathway genes have been noted in diverse cancers. Biochemical and genetic data support the idea that inhibition of Wnt/ß-catenin signaling is beneficial in cancer therapeutics. The interaction of this important pathway with other signaling systems is also noteworthy, but remains as an area for further research and discovery. In addition, formation of different complexes by components of the Wnt/ß-catenin pathway and the precise roles of these complexes in the cytoplasmic milieu are yet to be fully elucidated. This article highlights the latest medical technologies in imaging, single-cell omics, use of artificial intelligence (e.g., machine learning techniques), genome sequencing, quantum computing, molecular docking, and computational softwares in modeling interactions between molecules and predicting protein-protein and compound-protein interactions pertinent to the biology and therapeutic value of the Wnt/ß-catenin signaling pathway. We discuss these emerging technologies in relationship to what is currently needed to move from concept to actionable strategies in translating the Wnt/ß-catenin laboratory discoveries to Wnt-targeted cancer therapies and diagnostics in the clinic.


Asunto(s)
Susceptibilidad a Enfermedades , Neoplasias/etiología , Neoplasias/metabolismo , Vía de Señalización Wnt , Animales , Antineoplásicos/química , Antineoplásicos/farmacología , Antineoplásicos/uso terapéutico , Productos Biológicos/química , Productos Biológicos/farmacología , Productos Biológicos/uso terapéutico , Biomarcadores , Manejo de la Enfermedad , Sustitución de Medicamentos , Humanos , Terapia Molecular Dirigida , Neoplasias/diagnóstico , Neoplasias/terapia , Proteínas Wnt/metabolismo , Vía de Señalización Wnt/efectos de los fármacos , beta Catenina/metabolismo
3.
Development ; 145(11)2018 06 08.
Artículo en Inglés | MEDLINE | ID: mdl-29884654

RESUMEN

The Wnt-ß-catenin signaling pathway is an evolutionarily conserved cell-cell communication system that is important for stem cell renewal, cell proliferation and cell differentiation both during embryogenesis and during adult tissue homeostasis. Genetic or epigenetic events leading to hypo- or hyper-activation of the Wnt-ß-catenin signaling cascade have also been associated with human diseases such as cancer. Understanding how this pathway functions is thus integral for developing therapies to treat diseases or for regenerative medicine approaches. Here, and in the accompanying poster, we provide an overview of Wnt-ß-catenin signaling and briefly highlight its key functions during development and adult tissue homeostasis.


Asunto(s)
Comunicación Celular/fisiología , Proteínas Wnt/metabolismo , Vía de Señalización Wnt/fisiología , beta Catenina/metabolismo , Animales , Diferenciación Celular/fisiología , Proliferación Celular/fisiología , Autorrenovación de las Células/fisiología , Drosophila , Humanos , Células Madre/metabolismo
5.
São Paulo; s.n; 2014. [134] p. ilus, tab, graf.
Tesis en Portugués | LILACS | ID: lil-730864

RESUMEN

Introdução: Os mecanismos moleculares que levam ao desenvolvimento de tumores do córtex suprarrenal ainda são pouco compreendidos. Uma alta frequência de carcinomas adrenocorticais na infância tem sido relatada nas regiões sul e sudeste do Brasil, com a presença de uma única mutação germinativa do supressor tumoral p53 (p.R337H) sendo evidenciada em 80- 97% dos casos. Outros fatores implicados na tumorigênese adrenocortical incluem a hiperexpressão das vias IGF2 e Wnt. Os microRNAs, fragmentos de RNA que não codificam proteínas, são capazes de controlar a transcrição gênica exercendo um papel importante no crescimento e proliferação celular. O papel dos microRNA na tumorigênese adrenal ainda não está totalmente elucidado. Objetivos: Avaliar diferenças no perfil de expressão de microRNAs entre tumores benignos e malignos do córtex da suprarrenal da população adulta e pediátrica. Comparar esta expressão entre as amostras caracterizadas pela presença da mutação germinativa p.R337H do supressor tumoral p53, hiperexpressão da via Wnt e da via do IGF2. Métodos: Trinta e seis pacientes não relacionados, adultos e crianças, foram estudados. Os pacientes tiveram avaliação do perfil de produção hormonal e das vias moleculares p53, IGF2 e Wnt. O perfil de expressão de microRNAs foi determinado utilizando-se produto comercial específico TaqMan MicroRNA Human Array (AppliedBiosystems, Forster City, CA, USA). Os dados de expressão foram analisados com o programa Expression Suite (AppliedBiosystems, Forster City, CA, USA) e Realtime Statmainer (Integromics, Granada, Espanha). O estudo de alvos e das redes gênicas afetadas foram estudados com o programa Ingenuity - IPA (Ingenuity, EUA). Resultados: A comparação do perfil de expressão entre adenomas e carcinomas revelou alteração de expressão em 89 e 21 miRNAs em adultos e crianças, respectivamente. Após a correção estatística para múltiplos testes, nove miRNAs mantiveram diferenças significantes em adultos e nenhum em...


Introduction: The molecular mechanisms that lead to the development of tumors of the adrenal cortex are still poorly understood. A high frequency of pediatric adrenocortical carcinomas has been reported in South and Southeast of Brazil, and a single germline mutation of the tumor suppressor p53 (p.R337H) has been identified in 80-97% of cases. In addition, the overexpression of IGF2 and Wnt pathways are also involved in adrenal tumorigenesis. MicroRNAs, a class of small nonconding RNA, are able to control gene transcription regulating cellular growth and proliferation. However, the role of microRNA has not been fully elucidated in adrenal tumorigenesis. Objectives: To evaluate differences in the expression profile of microRNA between adult and pediatric adrenocortical tumors. To compare microRNA expression profile among samples with and without TP53, Wnt and IGF2 abnormalities. Methods: Thirty-six unrelated patients, adults and children, were studied. Patients had comprehensive hormonal evaluation and tumor samples were studied for TP53, Wnt and IGF2. The expression profile of microRNAs were determined using specific commercial product TaqMan MicroRNA Human Array (AppliedBiosystems, Forster City, CA, USA). The expression data were analyzed with the program Expression Suite (AppliedBiosystems, Forster City, CA, USA) and Realtime Statmainer (Integromics, Granada, Spain). The study of gene networks and affected targets genes have been studied with the Ingenuity program - IPA (Ingenuity, USA). Results: Comparing expression profile between adenomas and carcinomas revealed 89 and 21 deregulated miRNAs in adults and children, respectively. After false discovery rate correction, nine microRNA have maintained significant diferences in miRNAs between adults and none in children. Among microRNAs deregulated in adults were miR-483-3p (p = 0.011), miR-1290 (p = 0.011) and miR-106b (p = 0.048). These microRNAs were selected for evaluation as biomarkers through ROC curve....


Asunto(s)
Humanos , Masculino , Femenino , Niño , Adulto , Persona de Mediana Edad , Neoplasias de la Corteza Suprarrenal , Niño , Expresión Génica , Factor II del Crecimiento Similar a la Insulina , MicroARNs , Proteínas Wnt
6.
Artículo en Inglés | MEDLINE | ID: mdl-24834156

RESUMEN

Colorectal cancer is one of the most common malignancy in the world and the second cancer-related death, many molecular and genetic aspects of this disease have been cleared as chromosomal instability and the role of some key proteins as WNT/ß catenin, trypsin and others. Also recently the role of folate turnover and some neurotransmitters as serotonin were also considered. The scope of this review is to describe some details about new molecular pathways suggested for occurrence or progress of this disease.

7.
Artículo en Coreano | WPRIM (Pacífico Occidental) | ID: wpr-11386

RESUMEN

PURPOSE: To evaluate the effects of the Wnt protein on proliferation and stemness maintenance of cultured corneal limbal stem cells. METHODS: We examined the expression of Wnt proteins by Western blot analysis. We then evaluated the effects of Wnt on cell proliferation by colony forming efficiency. beta-catenin activation using Wnt proteins was examined by immunocytochemistry. We also examined the effects of Wnt on proliferation and stemness maintenance by reverse transcriptase polymerase chain reaction of p63 and connexin43. RESULTS: Wnt has a different effect on corneal epithelial stem cells. Colony forming efficiency was also significantly higher in treated Wnt2 and Wnt4 cells compared with controls. The Wnt2 and Wnt4 treated cells showed nuclear accumulation of beta-catenin. In addition, the limbal stem cell marker p63 was strongly expressed in Wnt2, Wnt4 Wnt5a, and Wnt5b. Connexin43 mRNA was also strongly expressed in Wnt5a, Wnt5b and Wnt7b cells. CONCLUSIONS: We suggest that Wnt2 and Wnt4 could lead to more effective proliferation and stemness maintenance for human corneal epithelial stem cells.


Asunto(s)
Humanos , beta Catenina , Western Blotting , Proliferación Celular , Conexina 43 , Inmunohistoquímica , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , ARN Mensajero , Células Madre , Proteínas Wnt
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA